Skip to content
Verana-logo-horizontal-5
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Oncology Qdata
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us
VeranaHealth_Logo
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Oncology Qdata
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us

Press

Verana Health Enhances MIPS Advisory Services to Help Medical Practices to Maximize Program Benefits, Reduce Compliance Burden, and Improve Patient Care 

October 7, 2025
Read More...

Verana Health Introduces Significant Data and Software Enhancements to Support Ophthalmologic Research and Treatment Optimization

October 2, 2025
Read More...

Verana Health Launches Qdata® Cataracts, the Largest Dataset of Its Kind for Cataract Research

April 23, 2025
Read More...

Verana Health Enhances Site Explorer Tool to Advance Diversity in Clinical Trials 

March 4, 2025
Read More...

Verana Health and Nanoscope Therapeutics Announce Collaboration to Accelerate Retinitis Pigmentosa Research

February 25, 2025
Read More...

Verana Health Debuts Qdata Explorer in Advance of American Academy of Ophthalmology 2024 Annual Meeting

October 9, 2024
Read More...

Verana Health Introduces Qdata Explorer in Advance of 2024 American Academy of Ophthalmology Annual Meeting

October 8, 2024
Read More...

Verana Health CEO Named PharmaVoice 100 Winner

October 8, 2024
Read More...

How The Healthcare Industry Can Use AI In Clinical Trial Recruitment

September 30, 2024
Read More...

Verana Health Announces Launch of Qdata® BPH

September 30, 2024
Read More...
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 25
  • Next »
VeranaHealth_Logo

San Francisco | New York | Knoxville

Search

© 2026 Verana Health. All Rights Reserved.

Privacy Policy

Cookie Policy